gene_symbol
SLAMF7
hgnc_id
HGNC:21394
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Elotuzumab binds SLAMF7 on myeloma cells; its Fc engages FcγRIIIa (CD16) on NK cells to trigger ADCC, and it also activates NK cells via SLAMF7, leading to lysis of SLAMF7-positive tumor cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05730036
disease_id_num_tar_ref
5624
drug_id_num_tar_ref
15296